@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix nalt: <https://lod.nal.usda.gov/nalt/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix ns0: <https://lod.nal.usda.gov/naltv#> .

<https://lod.nal.usda.gov/naltv#marc001> rdfs:label "Field 001 in MARC Authority Format"@en .
nalt:148769_def
  a <https://lod.nal.usda.gov/naltv#Definition> ;
  rdf:value "Semisynthetic derivative of erythromycin. It is concentrated by human phagocytes and is bioactive intracellularly. While the drug is active against a wide spectrum of pathogens, it is particularly effective in the treatment of respiratory and genital tract infections."@en, "Derivado semisintético de la eritromicina. Se concentra por fagocitos humanos y es bioactiva intracelularmente. Mientras que el fármaco es activo contra un amplio espectro de patógenos y particularmente eficaz en el tratamiento de infecciones del tracto respiratorio y genitales."@es ;
  dc:source "Medical Subject Headings 2011" .

<https://lod.nal.usda.gov/nalt>
  a skos:ConceptScheme ;
  rdfs:label "NALT Full"@en .

<https://lod.nal.usda.gov/naltv#Chemical>
  a owl:Class ;
  rdfs:label "Chemical"@en .

nalt:148769
  a <https://lod.nal.usda.gov/naltv#Chemical>, skos:Concept ;
  dc:created "2011-10-06"^^xsd:date ;
  dc:modified "2013-09-05"^^xsd:date ;
  skos:broader nalt:38103 ;
  skos:definition nalt:148769_def ;
  skos:inScheme <https://lod.nal.usda.gov/nalt> ;
  skos:prefLabel "roxitromicina"@es, "roxithromycin"@en ;
  ns0:marc001 "60081" .

nalt:38103
  a ns0:Chemical, skos:Concept ;
  skos:narrower nalt:148769 ;
  skos:prefLabel "eritromicina"@es, "erythromycin"@en .